J. Yue

A Phase I/II Multicenter, Open-Label Study of the Oral Histone Deacetylase Inhibitor Abexinostat in Relapsed/Refractory Lymphoma

Ying Luan, J. Vose, L. Gordon, 2015, Clinical Cancer Research.

High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants

David R. Jones, M. Ladanyi, E. Hubbell, 2019, Nature Medicine.

High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants

M. Ladanyi, E. Hubbell, C. Rudin, 2019, Nature Medicine.

Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA

D. Berry, S. Cummings, E. Fung, 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

A Phase II Multicenter Study of the Histone Deacetylase Inhibitor (HDACi) Abexinostat (PCI-24781) in Relapsed/Refractory Follicular Lymphoma (FL) and Mantle Cell Lymphoma (MCL)

J. Vose, L. Gordon, Lei Zhou, 2012 .